Identification of a pathogenic mutation in a Chinese pedigree with polycystic kidney disease

Kexian Dong1, Huanhuan Miao2, Xueyuan Jia1

  • 1Laboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.

Insights

A novel duplication variant in the PKD1 gene was identified as the cause of autosomal dominant polycystic kidney disease (ADPKD) in one family. This finding aids in understanding ADPKD genetics and diagnosis.

Area of Science:

  • Genetics and Molecular Biology
  • Nephrology
  • Inherited Diseases

Background:

  • Polycystic kidney disease (PKD) is a severe inherited disorder affecting 1 in 500–1,000 individuals globally.
  • The disease is characterized by the development of numerous cysts in both kidneys, leading to structural damage and impaired kidney function.
  • Autosomal dominant PKD (ADPKD) is the most common inherited kidney disease, primarily caused by mutations in the PKD1 gene.

Purpose of the Study:

  • To identify the genetic cause of PKD in a consanguineous family.
  • To characterize novel variants within the PKD1 gene.
  • To investigate the pathogenic role of identified variants in ADPKD.

Main Methods:

  • Whole exome sequencing was performed on the proband to identify potential causative genes.
  • Candidate gene segments were amplified using nested polymerase chain reaction.
  • Sanger sequencing was employed for precise variant detection and confirmation.

Main Results:

  • A novel duplication variant (NM_001009944.2:c.9359dupA:p.Y3120_E3121delinsX) was identified in the PKD1 gene.
  • A missense mutation (c.G9022A:p.V3008M) was also detected in the PKD1 gene.
  • The duplication variant, located in the polycystin-1, lipoxygenase, alpha-toxin domain, was confirmed as the pathogenic factor for ADPKD in this family.

Conclusions:

  • The identified duplication variant in PKD1 is the pathogenic cause of autosomal dominant PKD in the studied family.
  • Genetic analysis of PKD1 variants, including those in specific domains like the N-terminal region, is crucial for understanding ADPKD.
  • This study contributes to the genetic diagnosis and understanding of ADPKD, highlighting the importance of novel variant identification.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
89.2K
Mutations01:39

Mutations

Overview
94.5K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
725
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
641
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
466